Loss of Emi1-Dependent Anaphase-Promoting Complex/Cyclosome Inhibition Deregulates E2F Target Expression and Elicits DNA Damage-Induced Senescence

REFERENCES

• Ban, K. H., J. Z. Torres, J. J. Miller, A. Mikhailov, M. V. Nachury, J. J. Tung, C. L. Rieder, and P. K. Jackson. 2007. The END network couples spindle pole assembly to inhibition of the anaphase-promoting complex/cyclosome in early mitosis. Dev. Cell 13:29–42.
   PubMedGoogle Scholar
• Bartkova, J., Z. Horejsi, K. Koed, A. Kramer, F. Tort, K. Zieger, P. Guldberg, M. Sehested, J. M. Nesland, C. Lukas, T. Orntoft, J. Lukas, and J. Bartek. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864–870.
   PubMed Web of Science ®Google Scholar
• Bartkova, J., N. Rezaei, M. Liontos, P. Karakaidos, D. Kletsas, N. Issaeva, L. V. Vassiliou, E. Kolettas, K. Niforou, V. C. Zoumpourlis, M. Takaoka, H. Nakagawa, F. Tort, K. Fugger, F. Johansson, M. Sehested, C. L. Andersen, L. Dyrskjot, T. Orntoft, J. Lukas, C. Kittas, T. Helleday, T. D. Halazonetis, J. Bartek, and V. G. Gorgoulis. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633–637.
   PubMed Web of Science ®Google Scholar
• Bashir, T., N. V. Dorrello, V. Amador, D. Guardavaccaro, and M. Pagano. 2004. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428:190–193.
   PubMed Web of Science ®Google Scholar
• Bernis, C., S. Vigneron, A. Burgess, J. C. Labbe, D. Fesquet, A. Castro, and T. Lorca. 2007. Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCFβtrcp. EMBO Rep. 8:91–98.
   PubMedGoogle Scholar
• Binne, U. K., M. K. Classon, F. A. Dick, W. Wei, M. Rape, W. G. Kaelin, Jr., A. M. Naar, and N. J. Dyson. 2007. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat. Cell Biol. 9:225–232.
   PubMed Web of Science ®Google Scholar
• Blow, J. J., and A. Dutta. 2005. Preventing re-replication of chromosomal DNA. Nat. Rev. Mol. Cell. Biol. 6:476–486.
   PubMed Web of Science ®Google Scholar
• Botz, J., K. Zerfass-Thome, D. Spitkovsky, H. Delius, B. Vogt, M. Eilers, A. Hatzigeorgiou, and P. Jansen-Durr. 1996. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16:3401–3409.
   PubMed Web of Science ®Google Scholar
• Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193–199.
   PubMed Web of Science ®Google Scholar
• Clurman, B. E., R. J. Sheaff, K. Thress, M. Groudine, and J. M. Roberts. 1996. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1979–1990.
   PubMed Web of Science ®Google Scholar
• Cobrinik, D. 2005. Pocket proteins and cell cycle control. Oncogene 24:2796–2809.
   PubMed Web of Science ®Google Scholar
• Dabbeekeh, J. T., S. L. Faitar, C. P. Dufresne, and J. K. Cowell. 2007. The EVI5 TBC domain provides the GTPase-activating protein motif for RAB11. Oncogene 26:2804–2808.
   PubMedGoogle Scholar
• Di Micco, R., M. Fumagalli, A. Cicalese, S. Piccinin, P. Gasparini, C. Luise, C. Schurra, M. Garre, P. G. Nuciforo, A. Bensimon, R. Maestro, P. G. Pelicci, and F. d'Adda di Fagagna. 2006. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444:638–642.
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363–9367.
   PubMed Web of Science ®Google Scholar
• Ekholm-Reed, S., J. Mendez, D. Tedesco, A. Zetterberg, B. Stillman, and S. I. Reed. 2004. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J. Cell Biol. 165:789–800.
   PubMed Web of Science ®Google Scholar
• Eldridge, A. G., A. V. Loktev, D. V. Hansen, E. W. Verschuren, J. D. Reimann, and P. K. Jackson. 2006. The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1. Cell 124:367–380.
   PubMed Web of Science ®Google Scholar
• Geng, Y., E. N. Eaton, M. Picon, J. M. Roberts, A. S. Lundberg, A. Gifford, C. Sardet, and R. A. Weinberg. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12:1173–1180.
   PubMed Web of Science ®Google Scholar
• Hansen, D. V., A. V. Loktev, K. H. Ban, and P. K. Jackson. 2004. Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFβTrCP-dependent destruction of the APC inhibitor Emi1. Mol. Biol. Cell 15:5623–5634.
   PubMed Web of Science ®Google Scholar
• Hickson, I., Y. Zhao, C. J. Richardson, S. J. Green, N. M. Martin, A. I. Orr, P. M. Reaper, S. P. Jackson, N. J. Curtin, and G. C. Smith. 2004. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64:9152–9159.
   PubMed Web of Science ®Google Scholar
• Hsu, J. Y., J. D. Reimann, C. S. Sorensen, J. Lukas, and P. K. Jackson. 2002. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1). Nat. Cell Biol. 4:358–366.
   PubMed Web of Science ®Google Scholar
• Hwang, H. C., and B. E. Clurman. 2005. Cyclin E in normal and neoplastic cell cycles. Oncogene 24:2776–2786.
   PubMed Web of Science ®Google Scholar
• Koepp, D. M., L. K. Schaefer, X. Ye, K. Keyomarsi, C. Chu, J. W. Harper, and S. J. Elledge. 2001. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294:173–177.
   PubMed Web of Science ®Google Scholar
• Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, Jr., and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161–172.
   PubMed Web of Science ®Google Scholar
• Kuo, Y. L., and C. Z. Giam. 2006. Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J. 25:1741–1752.
   PubMedGoogle Scholar
• Lee, H., D. J. Lee, S. P. Oh, H. D. Park, H. H. Nam, J. M. Kim, and D. S. Lim. 2006. Mouse emi1 has an essential function in mitotic progression during early embryogenesis. Mol. Cell. Biol. 26:5373–5381.
   PubMedGoogle Scholar
• Lehman, N. L., E. W. Verschuren, J. Y. Hsu, A. M. Cherry, and P. K. Jackson. 2006. Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. Cell Cycle 5:1569–1573.
   PubMed Web of Science ®Google Scholar
• Machida, Y. J., and A. Dutta. 2007. The APC/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev. 21:184–194.
   PubMed Web of Science ®Google Scholar
• Maehara, K., K. Yamakoshi, N. Ohtani, Y. Kubo, A. Takahashi, S. Arase, N. Jones, and E. Hara. 2005. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53. J. Cell Biol. 168:553–560.
   PubMedGoogle Scholar
• Marangos, P., E. W. Verschuren, R. Chen, P. K. Jackson, and J. Carroll. 2007. Prophase I arrest and progression to metaphase I in mouse oocytes are controlled by Emi1-dependent regulation of APC(Cdh1). J. Cell Biol. 176:65–75.
   PubMedGoogle Scholar
• Margottin-Goguet, F., J. Y. Hsu, A. Loktev, H. M. Hsieh, J. D. Reimann, and P. K. Jackson. 2003. Prophase destruction of Emi1 by the SCF(βTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4:813–826.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., G. Rotman, A. Ogawa, Y. Shiloh, K. Tamai, and S. J. Elledge. 2000. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97:10389–10394.
   PubMed Web of Science ®Google Scholar
• McGarry, T. J., and M. W. Kirschner. 1998. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93:1043–1053.
   PubMed Web of Science ®Google Scholar
• Melixetian, M., A. Ballabeni, L. Masiero, P. Gasparini, R. Zamponi, J. Bartek, J. Lukas, and K. Helin. 2004. Loss of geminin induces rereplication in the presence of functional p53. J. Cell Biol. 165:473–482.
   PubMed Web of Science ®Google Scholar
• Miller, J. J., M. K. Summers, D. V. Hansen, M. V. Nachury, N. L. Lehman, A. Loktev, and P. K. Jackson. 2006. Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor. Genes Dev. 20:2410–2420.
   PubMed Web of Science ®Google Scholar
• Moberg, K. H., D. W. Bell, D. C. Wahrer, D. A. Haber, and I. K. Hariharan. 2001. Archipelago regulates cyclin E levels in drosophila and is mutated in human cancer cell lines. Nature 413:311–316.
   PubMed Web of Science ®Google Scholar
• Moshe, Y., J. Boulaire, M. Pagano, and A. Hershko. 2004. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome. Proc. Natl. Acad. Sci. USA 101:7937–7942.
   PubMed Web of Science ®Google Scholar
• Ohtani, K., J. DeGregori, and J. R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92:12146–12150.
   PubMed Web of Science ®Google Scholar
• Oruetxebarria, I., F. Venturini, T. Kekarainen, A. Houweling, L. M. Zuijderduijn, A. Mohd-Sarip, R. G. Vries, R. C. Hoeben, and C. P. Verrijzer. 2004. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. J. Biol. Chem. 279:3807–3816.
   PubMed Web of Science ®Google Scholar
• Peters, J. M. 2006. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell Biol. 7:644–656.
   PubMed Web of Science ®Google Scholar
• Reimann, J. D., E. Freed, J. Y. Hsu, E. R. Kramer, J. M. Peters, and P. K. Jackson. 2001. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105:645–655.
   PubMed Web of Science ®Google Scholar
• Shieh, S. Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325–334.
   PubMed Web of Science ®Google Scholar
• Sorensen, C. S., C. Lukas, E. R. Kramer, J. M. Peters, J. Bartek, and J. Lukas. 2000. Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol. Cell. Biol. 20:7613–7623.
   PubMed Web of Science ®Google Scholar
• Stiff, T., S. A. Walker, K. Cerosaletti, A. A. Goodarzi, E. Petermann, P. Concannon, M. O'Driscoll, and P. A. Jeggo. 2006. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 25:5775–5782.
   PubMed Web of Science ®Google Scholar
• Strohmaier, H., C. H. Spruck, P. Kaiser, K. A. Won, O. Sangfelt, and S. I. Reed. 2001. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413:316–322.
   PubMed Web of Science ®Google Scholar
• Sutterlüty, H., E. Chatelain, A. Marti, C. Wirbelauer, M. Senften, U. Muller, and W. Krek. 1999. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:207–214.
   PubMed Web of Science ®Google Scholar
• Tsvetkov, L. M., K. H. Yeh, S. J. Lee, H. Sun, and H. Zhang. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661–664.
   PubMed Web of Science ®Google Scholar
• Tung, J. J., and P. K. Jackson. 2005. Emi1 class of proteins regulate entry into meiosis and the meiosis I to meiosis II transition in Xenopus oocytes. Cell Cycle 4:478–482.
   PubMed Web of Science ®Google Scholar
• van Drogen, F., O. Sangfelt, A. Malyukova, L. Matskova, E. Yeh, A. R. Means, and S. I. Reed. 2006. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol. Cell 23:37–48.
   PubMedGoogle Scholar
• Wei, W., N. G. Ayad, Y. Wan, G. J. Zhang, M. W. Kirschner, and W. G. Kaelin, Jr. 2004. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428:194–198.
   PubMed Web of Science ®Google Scholar
• Welcker, M., J. Singer, K. R. Loeb, J. Grim, A. Bloecher, M. Gurien-West, B. E. Clurman, and J. M. Roberts. 2003. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell 12:381–392.
   PubMed Web of Science ®Google Scholar
• Westlake, C. J., J. R. Junutula, G. C. Simon, M. Pilli, R. Prekeris, R. H. Scheller, P. K. Jackson, and A. G. Eldridge. 2007. Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene. Proc. Natl. Acad. Sci. USA 104:1236–1241.
   PubMedGoogle Scholar
• Won, K. A., and S. I. Reed. 1996. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15:4182–4193.
   PubMed Web of Science ®Google Scholar
• Yeh, E. S., B. O. Lew, and A. R. Means. 2006. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J. Biol. Chem. 281:241–251.
   PubMed Web of Science ®Google Scholar
• Zhu, W., Y. Chen, and A. Dutta. 2004. Rereplication by depletion of geminin is seen regardless of p53 status and activates a G2/M checkpoint. Mol. Cell. Biol. 24:7140–7150.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., C. Alvarez, R. Doll, H. Kurata, X. M. Schebye, D. Parry, and E. Lees. 2004. Intra-S-phase checkpoint activation by direct CDK2 inhibition. Mol. Cell. Biol. 24:6268–6277.
   PubMed Web of Science ®Google Scholar
• Zou, L., and S. J. Elledge. 2003. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542–1548.
   PubMed Web of Science ®Google Scholar